Effectiveness of clopidogrel vs. ticagrelor based on the ABCD-GENE score in acute coronary syndrome patients following percutaneous coronary intervention
The ABCD-GENE score showed good predictive accuracy for a composite of ischemic and bleeding events and could identify patients likely to benefit from the ticagrelor-based antiplatelet strategy.
Authors
- Zizhao Qi (ORCID: https://orcid.org/0000-0003-4427-4399)
- Xueqing Yang
- Miaohan Qiu (ORCID: https://orcid.org/0000-0003-2077-5770)
- Jing Li (ORCID: https://orcid.org/0000-0003-4296-0256)
- Xiaozeng Wang (ORCID: https://orcid.org/0000-0003-1979-0287)
- Yaling Han (ORCID: https://orcid.org/0000-0003-4569-6737)
- Yi Li (ORCID: https://orcid.org/0000-0002-3875-3513)
- Xiaotong Xu (ORCID: https://orcid.org/0000-0003-3973-5410)
- Kai Xu (ORCID: https://orcid.org/0009-0003-2694-7892)
- Kun Na (ORCID: https://orcid.org/0000-0003-3679-8248)
Institutions
- Shenyang Pharmaceutical University (CN)
- Harbin Medical University (CN)
- General Hospital of Shenyang Military Region (CN)
- Second Affiliated Hospital of Harbin Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-06-11
- DOI
- https://doi.org/10.3389/fphar.2025.1606327
- Citations
- 1
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- National Key Research and Development Program of China